From the Desk of the CEO

Ten years have passed since SB 5557 was signed into law, making pharmacists in Washington state providers in private health plans.

Loren Bonner

GLP-1 receptor agonists, such as Wegovy, Ozempic, and Mounjaro, have been grabbing headlines since 2021 when they were first approved in the United States for weight loss. Their growth has outpaced all expectations, with seemingly everyone knowing someone—family, friends, neighbors, or coworkers—who have used or is using one of these medications.

Elizabeth Briand

At least 25% of seasoned pharmacy leaders will leave their positions earlier than expected, according to ASHP’s 2023 Pharmacy Forecast. This turnover, coupled with the already growing demand for pharmacy leaders, highlights the importance of younger pharmacists learning from those in leadership positions.

Lauren Howell, PharmD

A decision from February 13, 2026, by the United States Court of Appeals for the Fifth Circuit provides a rare opportunity for celebration.

David B. Brushwood, BSPharm, JD

Pharmacists in Delaware can now be reimbursed for a broad scope of patient care services within the state’s Medicaid program as well as with all commercial insurers in the state.

Loren Bonner